ASCO 2024 Highlights Part 1 - Plenary
Podcast | English | 2024 | 48 Min
Image For Activity Cover
Cost
$0.00
Credit
No Credit Offered

ASCO 2024 presented so much lung cancer data that two podcast episodes are required to cover all the data. In this first episode, hosts Dr. Stephen Liu and Dr. Narjust Florez cover the LAURA trial, the ADUARA trial, the KRYSTAL-12 study, the phase III EVOKE-01 trial, the phase III ADRIATIC trial, and the REACH-PC trial.

Podcast Hosts:
  • Narjust Florez, MD, Associate Director of the Cancer Care Equity Program and Thoracic Medical Oncologist, Dana-Farber Cancer Institute; Assistant Professor of Medicine, Harvard Medical School, Boston, MA, USA  
  • Stephen Liu, MD, Associate Professor of Medicine, Director of Thoracic Oncology and Director of Developmental Therapeutics, Georgetown Lombardi Comprehensive Cancer Center, Washington, D.C., USA 

Podcast Guests: 

  • Lecia Sequist, MD, MPH, Program Director for Cancer Early Detection & Diagnostics, Massachusetts General Cancer Center; Landry Family Professor of Medicine in the Field of Medical Oncology at Harvard Medical School, Boston, MA, USA
  • David Spigel, MD, Chief Scientific Officer, Sarah Cannon Research Institute; IASLC Heine H. Hansen Lectureship for SCLC Recipient, Nashville, TN, USA
Powered By